Add to ORKGPenetration of peritoneal dialysis (PD) varies tremen-dously across the world. It ranges from about 80 % in Hong Kong and Mexico to just a few percentage points in th
The number of patients with end-stage renal disease (ESRD) has rapidly increased, as has the cost of...
Background: Extending technique survival on peritoneal dialysis (PD) remains a major challenge in op...
In this issue of Peritoneal Dialysis International, the study by Franco et al. suggests that assiste...
p eritoneal dialysis has evolved considerably over the last three decades. The dramatic increase in ...
As the global burden of chronic kidney disease continues to increase, so does the need for a cost-ef...
In many countries, the use of peritoneal dialysis (PD) remains low despite arguments that support it...
Rationale & objectiveApproximately 11% of people with kidney failure worldwide are treated with ...
Rationale & objectiveApproximately 11% of people with kidney failure worldwide are treated with ...
Rationale & objectiveApproximately 11% of people with kidney failure worldwide are treated with ...
RATIONALE & OBJECTIVE Approximately 11% of people with kidney failure worldwide are treated with ...
Prevalence and incidence of peritoneal dialysis (PD) in Asia are both increasing, but the increase i...
Rationale & Objective: Approximately 11% of people with kidney failure worldwide are treated with pe...
BACKGROUND AND OBJECTIVES: Quantifying contemporary peritoneal dialysis time on therapy is important...
BACKGROUND AND OBJECTIVES: Quantifying contemporary peritoneal dialysis time on therapy is important...
BACKGROUND AND OBJECTIVES: Quantifying contemporary peritoneal dialysis time on therapy is important...
The number of patients with end-stage renal disease (ESRD) has rapidly increased, as has the cost of...
Background: Extending technique survival on peritoneal dialysis (PD) remains a major challenge in op...
In this issue of Peritoneal Dialysis International, the study by Franco et al. suggests that assiste...
p eritoneal dialysis has evolved considerably over the last three decades. The dramatic increase in ...
As the global burden of chronic kidney disease continues to increase, so does the need for a cost-ef...
In many countries, the use of peritoneal dialysis (PD) remains low despite arguments that support it...
Rationale & objectiveApproximately 11% of people with kidney failure worldwide are treated with ...
Rationale & objectiveApproximately 11% of people with kidney failure worldwide are treated with ...
Rationale & objectiveApproximately 11% of people with kidney failure worldwide are treated with ...
RATIONALE & OBJECTIVE Approximately 11% of people with kidney failure worldwide are treated with ...
Prevalence and incidence of peritoneal dialysis (PD) in Asia are both increasing, but the increase i...
Rationale & Objective: Approximately 11% of people with kidney failure worldwide are treated with pe...
BACKGROUND AND OBJECTIVES: Quantifying contemporary peritoneal dialysis time on therapy is important...
BACKGROUND AND OBJECTIVES: Quantifying contemporary peritoneal dialysis time on therapy is important...
BACKGROUND AND OBJECTIVES: Quantifying contemporary peritoneal dialysis time on therapy is important...
The number of patients with end-stage renal disease (ESRD) has rapidly increased, as has the cost of...
Background: Extending technique survival on peritoneal dialysis (PD) remains a major challenge in op...
In this issue of Peritoneal Dialysis International, the study by Franco et al. suggests that assiste...